Latest news about Sree Rayalaseema Hi-Strength Hypo
Sree Rayalaseema Hi-Strength Hypo
605.75
+18.25(+3.11%)
Company Performance:
View Company Insights1D+3.11%
1M+28.02%
6M+46.02%
1Y+0.02%
5Y+77.69%
More news about Sree Rayalaseema Hi-Strength Hypo
02Jun 26
Sree Rayalaseema FY26 profit rises, dividend declared
Sree Rayalaseema Hi-Strength Hypo Limited reported a net profit of ₹9269.56 lakh for FY26, a marginal increase from the previous year. For Q4FY26, net profit declined to ₹2057.20 lakh. The Board recommended a final dividend of ₹3 per share.
14May 26
Sree Rayalaseema Hi-Strength Hypo Schedules Board Meeting on May 30, 2026 to Approve FY26 Audited Results
Sree Rayalaseema Hi-Strength Hypo Limited has scheduled a board meeting on May 30, 2026, to approve standalone and consolidated audited financial results for Q4 and the full financial year ended March 31, 2026. The board will also consider recommending a final dividend for FY ending March 31, 2026. The trading window for the company's shares has been closed since April 1, 2026, and will reopen 48 hours after the declaration of results. The intimation was filed on May 14, 2026, under Regulation 29 of SEBI (LODR) Regulations, 2015.
14Apr 26
Sree Rayalaseema Hi-Strength Hypo Reports Physical Share Transfer Progress Under SEBI Window
Sree Rayalaseema Hi-Strength Hypo Limited has submitted its March 2026 progress report on physical share transfer requests under SEBI's special window, showing 1 request received and processed but ultimately rejected with a 2-day processing time. The company maintains its special window for physical share transfers until February 2027 and continues participating in the IEPFA KYC update campaign to help shareholders avoid dividend-related complications.
07Apr 26
Sree Rayalaseema Hi-Strength Hypo Limited Submits Q4 FY26 SEBI Compliance Certificate
Sree Rayalaseema Hi-Strength Hypo Limited submitted its mandatory Q4 FY26 certificate under SEBI regulation 74(5) on April 07, 2026, covering the quarter ending March 31, 2026. The certificate, confirmed by RTA Aarthi Consultants Private Limited, demonstrates compliance with dematerialization requirements and proper handling of securities. The submission was made to both BSE and NSE, reflecting the company's commitment to regulatory compliance and corporate governance standards.
04Apr 26
Sree Rayalaseema Hi-Strength Hypo Limited Confirms Non-Applicability of Large Corporate Framework for FY26
Sree Rayalaseema Hi-Strength Hypo Limited has confirmed to stock exchanges that it does not qualify as a Large Corporate under SEBI's regulatory framework for FY26. The company reported zero outstanding borrowings as of March 31, 2026, and no credit rating, placing it outside the Large Corporate classification criteria established by SEBI Circular dated November 26, 2018.
18Mar 26
Sree Rayalaseema Hi-Strength Hypo Reports Zero Physical Share Transfer Requests in February 2026
Sree Rayalaseema Hi-Strength Hypo Limited reported zero physical share transfer requests during February 2026 under SEBI's special window provision. The company filed compliance reports with BSE and NSE showing nil activity across all parameters including requests received, processed, approved, and rejected. Aarthi Consultants Private Limited, the company's registrar and transfer agent, confirmed the status in accordance with SEBI Circular dated January 30, 2026.
14Feb 26
Sree Rayalaseema Hi-Strength Hypo Reports Q3FY26 Financial Results with Revenue of ₹14,117.40 Lakhs
Sree Rayalaseema Hi-Strength Hypo Limited reported Q3FY26 results with revenue from operations at ₹14,117.40 lakhs and net profit of ₹2,434.69 lakhs. For nine months ended December 31, 2025, revenue reached ₹50,381.93 lakhs with net profit of ₹7,212.37 lakhs, showing growth over previous year. The company operates primarily in chemicals segment with facilities in India.
30May 25
SREE RAYALASEEMA HI-STRENGTH HYPO Announces Dividend and Reports Mixed Q4 Results
SREE RAYALASEEMA HI-STRENGTH HYPO has released its Q4 financial results, showing a decrease in EBITDA to ₹179.00 million from ₹271.00 million year-over-year. The EBITDA margin contracted to 11.17% from 16.39%. Despite the decline, the company declared a dividend of 3.00 rupees per share.
Industry Peers
Deepak Fertilisers & Petrochemicals
Tata Chemicals
Gujarat Narmada Valley Fert & Chem
TANFAC Industries
Gujarat Alkalies & Chemicals
Grauer & Weil
GHCL
Chemplast Sanmar
JG Chemicals
Fischer Medical Ventures
1,361.40
(-1.79%)
652.20
(-2.64%)
625.10
(+0.33%)
3,403.00
(-0.67%)
620.80
(-1.93%)
86.69
(+0.59%)
421.30
(-0.64%)
192.65
(-3.39%)
601.75
(-3.19%)
34.23
(-2.28%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
